Charles A Scanga Selected Research

Biomarkers (Surrogate Marker)

1/2023	Antibody glycosylation correlates with disease progression in SIV-Mycobacterium tuberculosis coinfected cynomolgus macaques.
10/2018	Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.
1/2017	Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles A Scanga Research Topics

Disease

21	Tuberculosis (Tuberculoses) 11/2023 - 12/2003
20	Infections 04/2024 - 08/2003
7	Granuloma 12/2023 - 01/2017
3	Pulmonary Tuberculosis 11/2023 - 08/2014
2	COVID-19 04/2024 - 01/2020
2	Inflammation (Inflammations) 01/2017 - 01/2007
2	Pneumonia (Pneumonitis) 01/2017 - 01/2017
1	Breakthrough Infections 04/2024
1	Measles 04/2024
1	Reinfection 12/2023
1	Disease Progression 01/2023
1	Lung Diseases (Lung Disease) 01/2022
1	Influenza in Birds (Avian Flu) 01/2017
1	Coinfection 01/2017
1	Cytokine Release Syndrome 01/2017
1	Toxoplasmosis 06/2002

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 04/2024 - 05/2012
5	CytokinesIBA 01/2017 - 04/2005
5	Interleukin-12 (IL 12)IBA 12/2005 - 06/2002
4	LigandsIBA 12/2023 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
4	AerosolsIBA 01/2020 - 12/2003
3	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	AntigensIBA 01/2019 - 01/2007
3	Messenger RNA (mRNA)IBA 01/2007 - 08/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2005 - 11/2003
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2017
2	EnzymesIBA 01/2017 - 03/2010
1	SARS-CoV-2 spike proteinIBA 04/2024
1	Interleukin-15 (Interleukin 15)IBA 12/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	Moxifloxacin (Avelox)FDA Link 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Immunodominant EpitopesIBA 01/2023
1	Conditioned Culture MediaIBA 01/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2023
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2023
1	Clofazimine (Lamprene)FDA Link 02/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	BCG Vaccine FDA Link 01/2020
1	IntegrinsIBA 01/2017
1	PeptidomimeticsIBA 01/2017
1	AntioxidantsIBA 01/2017
1	AlbuminsIBA 01/2017
1	Tuberculosis VaccinesIBA 01/2017
1	Integrin alpha4beta1 (VLA-4)IBA 01/2017
1	Heme Oxygenase-1IBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Histocompatibility Antigens Class IIBA 05/2012
1	Leukotriene A4IBA 03/2010
1	EicosanoidsIBA 03/2010
1	HydrolasesIBA 03/2010
1	AcidsIBA 01/2007
1	lipoxin A4IBA 06/2005
1	LipoxinsIBA 06/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2005
1	Myeloid Differentiation Factor 88IBA 11/2003
1	Toll-Like Receptor 2IBA 11/2003

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2017
1	Intravenous Administration 01/2020